PDLIM7 and neoplasm: LMP, which is expressed in the tumor cells of EBV-associated malignancies, is a natural candidate target for cytotoxic T lymphocytes (61), and patients who received LMP-specific cytotoxic T cells achieved better PFS and OS and less toxicity (62, 63).